Impact of Systemic Health Conditions on Dental Implant Success: A Narrative Review

Dr. Deepthi Dandu¹, Dr. Urmi Reshamdalal^2, , Dr. Irram Fatima³, Dr. Syed Ammar Ali⁴, Dr. Karen Michelle Izquierdo⁵, Dr. Neha Sahu⁶ and Dr. Sandeep Singh⁷

¹BDS, Sharavathi Dental College and Hospital, Shimoga. (Rajiv Gandhi University of Health Sciences) India

²BDS, Vaidik Dental College and Research Center, Daman, Gujarat, India

³BDS, Sri Balaji Dental College, Hyderabad, India

⁴Ms In Healthcare Informatics, University - Depaul University - 1 E Jackson Blvd, Chicago, IL 60604

⁵DMD, Universidad Catolica de Santiago de Guayaquil, Av. Carlos Julio Arosemena

⁶BDS, RDH, Hitkarini Dental College and Hospital, Jabalpur, India

⁷MDS, Post Graduate Institute of Dental Sciences, Rohtak, India

Cite this paper:
Dr. Deepthi Dandu, Dr. Urmi Reshamdalal, Dr. Irram Fatima, Dr. Syed Ammar Ali, Dr. Karen Michelle Izquierdo, Dr. Neha Sahu and Dr. Sandeep Singh. Impact of Systemic Health Conditions on Dental Implant Success: A Narrative Review. American Journal of Clinical Medicine Research. 2026; 14(1):8-14. doi: 10.12691/ajcmr-14-1-2

Abstract

Background: Dental implants are a predictable and highly successful treatment modality; however, their long-term success is closely influenced by the patient’s systemic health. As implant therapy is increasingly requested by medically compromised patients, understanding the impact of systemic conditions on implant outcomes is essential. Objective: This review aims to evaluate current evidence on the influence of systemic health conditions on dental implant success and to provide clinically relevant considerations for managing such patients. Methods: A literature search was conducted in PubMed, Scopus, and Embase, including clinical trials, cohort studies, and systematic reviews published over the past two decades that examined the relationship between systemic diseases and dental implant outcomes. Results: Several systemic conditions, including uncontrolled diabetes mellitus, cardiovascular disease, osteoporosis, obesity, autoimmune disorders, smoking, and chronic kidney or liver disease, were associated with impaired healing, compromised bone quality, and reduced implant stability. Additionally, medication-related factors such as bisphosphonate therapy and long-term immunosuppression were identified as contributing risks for implant-related complications. Conclusion: Systemic health status plays a critical role in dental implant success. Thorough medical evaluation, optimization of systemic conditions, and individualized treatment planning are essential to improve outcomes in medically compromised patients. Interdisciplinary collaboration and evidence-based decision-making are key to achieving safe and predictable implant therapy.

Keywords:
Dental Implant Systemic Health Diabetes Osteoporosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Moraschini V, Poubel LA, Ferreira VF, Barboza EDS. Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg. 2015; 44(3): 377–388.
[2]	Kupka JR, König J, Al-Nawas B, Sagheb K, Schiegnitz E. How far can we go? A 20-year meta-analysis of dental implant survival rates. Clin Oral Investig. 2024; 28(10): 541.
[3]	Aghaloo T, Pi-Anfruns J, Moshaverinia A, Sim D, Grogan T, Hadaya D. The effects of systemic diseases and medications on implant osseointegration: a systematic review. Int J Oral Maxillofac Implants. 2019; 34(Suppl): s35–s49.
[4]	Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med. 2003; 14(4): 305–316.
[5]	D’Ambrosio F, Amato A, Chiacchio A, Sisalli L, Giordano F. Do systemic diseases and medications influence dental implant osseointegration and dental implant health? An umbrella review. Dent J (Basel). 2023; 11(6): 146.
[6]	Cosola S, Butera A, Zergaw AH, George J, Covani U, Arrighi A, et al. Glycemic control and implant stability in patients with type II diabetes: a narrative review. Healthcare (Basel). 2025; 13(5): 449.
[7]	Hamadé L, El-Disoki S, Chrcanovic BR. Hypertension and dental implants: a systematic review and meta-analysis. J Clin Med. 2024; 13(2): 499.
[8]	Chatzopoulos GS, Wolff LF. Effect of antiplatelet and anticoagulant medications on implant survival: a long-term retrospective cohort study. Oral Maxillofac Surg. 2025; 29(1): 43.
[9]	Kim SY, Lee YJ, Kang YJ, Kim SG, Rotaru H. Impact of osteoporosis on dental implant survival, failure, and marginal bone loss: a systematic review and meta-analysis. J Clin Med. 2025; 14(19): 6719.
[10]	AlRowis R, Aldawood A, AlOtaibi M, Alnasser E, AlSaif I, Aljaber A, et al. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dent J. 2022; 34(3): 202–210.
[11]	Shroff Y. Smoking and implant failure: an evidence-based review. IOSR J Dent Med Sci. 2018; 17(4): 60–64.
[12]	Mustapha AD, Salame Z, Chrcanovic BR. Smoking and dental implants: a systematic review and meta-analysis. Medicina (Kaunas). 2022; 58(1): 39.
[13]	Cotterell A, Griffin M, Downer MA, Parker JB, Wan D, Longaker MT. Understanding wound healing in obesity. World J Exp Med. 2024; 14(1): 86898.
[14]	Steeds SC, Zhou MX, Ganesh R, Rasmussen CM, Carr AB, Gruwell SF. Risk of dental implant failure with obesity. Int J Oral Maxillofac Implants. 2025; 40(1): 76–82.
[15]	Hyldahl E, Schliephake H, Jensen SS. Dental implant therapy in patients with autoimmune diseases: a scoping review. Clin Oral Implants Res. 2025; 36(8): 913–929.
[16]	Duttenhoefer F, Fuessinger MA, Beckmann Y, Schmelzeisen R, Groetz KA, Boeker M. Dental implants in immunocompromised patients: a systematic review and meta-analysis. Int J Implant Dent. 2019; 5(1): 43.
[17]	Yoon DL, Kim YG, Cho JH, Lee SK, Lee JM. Long-term evaluation of teeth and implants during periodic maintenance in patients with viral liver disease. J Adv Prosthodont. 2016; 8(4): 321–328.
[18]	Torrejon-Moya A, Izquierdo-Gómez K, Pérez-Sayáns M, Jané-Salas E, Marí-Roig A, López-López J. Patients with thyroid disorder: a contraindication for dental implants? A systematic review. J Clin Med. 2022; 11(9): 2399.
[19]	Sivakumar I, Indumathi S, et al. Does HIV infection affect the survival of dental implants? A systematic review and meta-analysis. J Prosthet Dent. 2021; 125(6): 862–869.
[20]	Bacci C, Schiazzano C, Zanon E, Stellini E, Sbricoli L. Bleeding disorders and dental implants: review and clinical indications. J Clin Med. 2023; 12(14): 4757.
[21]	Yacine A, Zain Ali M, Alharbi AB, Alanaz HQ, Alrahili SA, Alkhdairi AA. Chronic inflammation: a multidisciplinary analysis of shared pathways in autoimmune, infectious, and degenerative diseases. Cureus. 2025; 17(4): e82579.
[22]	Ouanounou A, Hassanpour S, Glogauer M. The influence of systemic medications on osseointegration of dental implants. J Can Dent Assoc. 2016; 82: g7.
[23]	Roy TK, Secomb TW. Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function. Microcirculation. 2021; 28(3): e12673.
[24]	Lemos CAA, de Oliveira AS, Faé DS, Oliveira HFFE, Rosa CDRD, Bento VAA, et al. Do dental implants placed in patients with osteoporosis have higher risks of failure and marginal bone loss? A systematic review and meta-analysis. Clin Oral Investig. 2023; 27(6): 2483–2493.
[25]	Huang M, Wang C, Li P, Lu H, Li A, Xu S. Role of immune dysregulation in peri-implantitis. Front Immunol. 2024; 15: 1466417.
[26]	Baghalipour N, Moztarzadeh O, Micopulos C, Samara W, Hauer L. Identified medications causing medication-related osteonecrosis of the jaw: a literature review. Cureus. 2025; 17(6): e86645.
[27]	Zidrou C, Kapetanou A, Rizou S. The effect of drugs on implant osseointegration: a narrative review. Injury. 2023; 54(8): 110888.
[28]	Nourah D, Aldahlawi S, Andreana S. Should the quality of glycemic control guide dental implant therapy in patients with diabetes? Focus on implant survival. Curr Diabetes Rev. 2022; 18(4): e060821195367.
[29]	de Oliveira MA, Asahi DA, Silveira CAE, Lima LAPA, Glick M, Gallottini M. Effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: a histological and histomorphometrical evaluation in rats. Clin Oral Implants Res. 2015; 26(4): e17–e21.
[30]	Végh D, Bencze B, Banyai D, et al. Preoperative HbA1c and blood glucose measurements in diabetes mellitus before oral surgery and implantology treatments. Int J Environ Res Public Health. 2023; 20(6): 4745.
[31]	Samara W, Moztarzadeh O, Hauer L, Babuska V. Dental implant placement in medically compromised patients: a literature review. Cureus. 2024; 16(2): e54199.
[32]	Gulati M, Govila V, Anand V, Anand B. Implant maintenance: a clinical update. ISRN Dent. 2014; 2014: 908534.
[33]	Hung M, Birmingham WC, Tucker M, Schwartz C, Mohajeri A. Integrating dentistry into interprofessional healthcare: a scoping review on advancing collaborative practice and patient outcomes. Healthcare (Basel). 2025; 13(21): 2780.
[34]	Mohammadi A, Dehkordi NR, Mahmoudi S, et al. Effects of drugs and chemotherapeutic agents on dental implant osseointegration: a narrative review. Curr Rev Clin Exp Pharmacol. 2023; 19(1): 42–60.
[35]	McGowan T, Han P, Ivanovski S. Biomarkers for implant dentistry studies. In: Biomarkers in Oral and Dental Research. Cham: Springer; 2023. p. 399–412.
[36]	Molla G, Bitew M. Revolutionizing personalized medicine: synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines. 2024; 12(12): 2750.
[37]	Zhang C, Fan L, Zhang S, Zhao J, Gu Y. Deep learning-based dental implant failure prediction from periapical and panoramic films. Quant Imaging Med Surg. 2023; 13(2): 935–945.